1Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of choronic heart failure in the adult [ J ]. Circulation, 2005,112 : 1825-1852.
6Chobannian AV, Bakirs GL, Black HR, et al. The seventh report of Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: JNC 7 report [ J ]. JAMA, 2003, 289 : 2560-2572.
7The Heart Outcomes Prevention Evaluation Study Invenstigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high sick patients [ J ]. N Engl J Med,2000,342:145-153.
9Swedberg K, Laland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ). The Task force for the Diagnosis and Treatment of chronic Heart Failure of the European Society of Cardiologr[ J ]. Eur Heart J, 2005,26(11) :1115-1140.
10Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systemic overview of date from individual patients [ J ]. Lancet, 2000,355 (9215) : 1575-1581.
3Pfeffer MA,Braunwald E,Moye LA,et al.Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction.Results of the survival and ventricular enlargement trial[J].N Engl J Med,1992,327:669-677.
4Dickstein K,Kjekshus J.Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction:the OPTIMAAL randomized trial[J].Lancet,2002,360:752-760.
5Dbrgie HJ.Effect of carvedilol on outcome after myocardial infartion in patients with left ventricular dysfunction:the CAPRICORN randomized trial[J].Lancet,2001,357:1385-1390.
6Moss AJ,Zebraba W,Hall WJ,et al.Multicenter Automatic Defibrillator Implantation TrialⅡ Investigators:Prophylactic implantation of a defibrillation in patients with myocardial infarction and reduced ejection fraction[J].N Engl J Med,2002,346:877-883.
7Gregoratos G,Abram J,Epstein AE,et al.ACC/AHA/NASPE 2002 guideline for implantation of cardiac pacemakers and antiarrhythmia device[J].J Cardiovasc Electrophysiol,2002,13:1183-1199.
8Cohn JN,Tognoni G.A randomized trial of the angiotensin receptor blocker valsartan in chronic heart failure[J].N Engl J Med,2001,345:1667-1675.
9Pfeffer MA,Swedberg K,Granger CB,et al.CHARM Investigators and Committee:Effects of candesartan on mortality and morbidity in patients with heart failure:the CHARM-Overall programme[J].Lancet,2003,362:759-766.
10Ditt B,Remme W,Zannad F,et al.Eplerenoen,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348:1309-1321.
